Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Wellington Management in the transaction. Metsera, a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity...
Metsera’s $215 Million Series B Financing Round
MBX Biosciences’ $115 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised MBX Biosciences on the deal while WilmerHale advised Wellington Management. MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision...